insights_auto
Kwa nini EPRX imepungua kwa 7.77%?
Fahamu zaidichevron_right
EPRX:TSE
Eupraxia Pharmaceuticals Inc
CA$ 10.32
arrow_downward
-7.77%(-0.87) Siku 1
2 Okt, 16:00:00 GMT -4 · CAD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EPRX...
Fungua
CA$ 11.36
Juu
CA$ 11.41
Chini
CA$ 10.26
Mtaji wa soko
671.00M
Wastani wa kiasi cha mauzo
elfu 82.24
Kiasi cha mauzo ya hisa
elfu 171.00
Juu kwa wiki 52
CA$ 13.08
Chini kwa wiki 52
CA$ 7.35
EPS
-CA$ 1.34
Beta
1.05
Hisa za wawekezaji
65.91M
Idadi ya wafanyakazi
49
Fungua
CA$ 11.36
Juu
CA$ 11.41
Chini
CA$ 10.26
Mtaji wa soko
671.00M
Wastani wa kiasi cha mauzo
elfu 82.24
Kiasi cha mauzo ya hisa
elfu 171.00
Juu kwa wiki 52
CA$ 13.08
Chini kwa wiki 52
CA$ 7.35
EPS
-CA$ 1.34
Beta
1.05
Hisa za wawekezaji
65.91M
Idadi ya wafanyakazi
49
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
kalkine.ca
·
saa 12 zilizopita
Eupraxia Pharmaceuticals (TSX:EPRX) Stock Drops 13.86% After 52-Week RESOLVE Data as Phase 2b Readout Moves to December
kalkine.ca
·
saa 12 zilizopita
Eupraxia Pharmaceuticals Stock Falls 13.86% as Clinical Validation Remains Central to the Outlook
Kalkine Media
·
siku 1 iliyopita
How Is Eupraxia Pharmaceuticals (TSX:EPRX) Using Drug Delivery Technology To Target Inflammatory Diseases?
TipRanks
·
siku 2 zilizopita
Eupraxia Pharmaceuticals Posts Strong 52-Week EoE Data for EP-104GI in RESOLVE Trial
Kuhusu Eupraxia Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi49
Lilianzishwa2011
Makao makuuVictoria, British Kolumbia, Kanada
Sekta-
Tovutieupraxiapharma.com